TMEM103 in Eosinophil Development
TMEM103 in Eosinophil Development
批准号:
7660267
负责人:
Gerald J Gleich
金额:
$18.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-15 至 2011-01-31
关键词:
AllergicAmino Acid SequenceAsthmaAtopic DermatitisBone MarrowBone Marrow CellsCD34 geneCellsChronicDevelopmentDiseaseEventExtrinsic asthmaGenesGenetic TranscriptionGrantHematopoietic stem cellsImmuneImmunityImmunohistochemistryIntegral Membrane ProteinInterleukin-5LeukocytesLocationMass Spectrum AnalysisMessenger RNAMethylcelluloseMicroscopyMonoclonal AntibodiesMorphologyNamesPAWR proteinPeptide Sequence DeterminationPharmaceutical PreparationsProductionProteinsQuantitative MicroscopyRNA InterferenceReactionResearchReverse Transcriptase Polymerase Chain ReactionRibosomesRoleSedimentation processSignal TransductionSucroseTimeTissuesTranscriptTranslatingUrticariaWestern BlottingdensityeosinophilmRNA Expressionnovelpolyclonal antibodypublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Eosinophils are associated with many allergic diseases including asthma, atopic dermatitis, drug reactions and chronic urticaria. The myriad of eosinophil related diseases has led us to investigate the development of eosinophils from hematopoietic stem cells in an attempt to understand the signals prompting eosinophil production in the bone marrow. Gene profiling of developing eosinophils has shown that a novel hypothetical protein is expressed as mRNA. TMEM103 mRNA is expressed in IL-5 stimulated CD34+ cells, bone marrow and in mature eosinophils. The transcript, TMEM103, has been shown to be associated with ribosomes and the protein has been identified by western blot analysis in developing eosinophils. This grant proposes to further verify the existence of TMEM103 by raising monoclonal antibodies to the protein, then purifying and sequencing the protein. Further, the function of TMEM103 will be investigated by RNA silencing followed by studies investigating morphological and transcription profile changes. PUBLIC HEALTH RELEVANCE: Eosinophils are leukocytes associated with asthma and allergic diseases. This project explores the role of TMEM103, a novel protein, in eosinophils.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein
-
批准号:10401936
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2021
-
负责人:Gerald J Gleich
-
依托单位:
Development of a Treatment for Eosinophil-Mediated Allergic Inflammatory Diseases Utilizing a Neutralizing Agent Targeting Eosinophil Granule Major Basic Protein
-
批准号:10257909
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2021
-
负责人:Gerald J Gleich
-
依托单位:
Novel, Non-InvasiveImaging of Eosinophil-Related Inflammation Throughout the Esophagus in Patients withEosinophilic Esophagitis
-
批准号:10017684
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:Gerald J Gleich
-
依托单位:
TMEM103 in Eosinophil Development
-
批准号:7768508
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2009
-
负责人:Gerald J Gleich
-
依托单位:
STANDARD VALUES OF EOSINOPHIL-RELATED PARAMETERS FOR DATA COMPARISON
-
批准号:7718523
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2008
-
负责人:Gerald J Gleich
-
依托单位:
CLINICAL TRIAL: ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
-
批准号:7718517
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2008
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
-
批准号:7718504
-
项目类别:
-
资助金额:$0.37万
-
财政年份:2008
-
负责人:Gerald J Gleich
-
依托单位:
ICATIBANT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA
-
批准号:7604975
-
项目类别:
-
资助金额:$1.04万
-
财政年份:2007
-
负责人:Gerald J Gleich
-
依托单位:
STANDARD VALUES OF EOSINOPHIL-RELATED PARAMETERS FOR DATA COMPARISON
-
批准号:7604980
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2007
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
-
批准号:7604962
-
项目类别:
-
资助金额:$2.35万
-
财政年份:2007
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB - OPEN LABEL
-
批准号:7376452
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2006
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
-
批准号:7376448
-
项目类别:
-
资助金额:$2.45万
-
财政年份:2006
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
-
批准号:7201430
-
项目类别:
-
资助金额:$2.64万
-
财政年份:2005
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB - OPEN LABEL
-
批准号:7201436
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2005
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
-
批准号:7058239
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2004
-
负责人:Gerald J Gleich
-
依托单位:
Eosinophilia myalgia syndrome
-
批准号:7044772
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2004
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
-
批准号:6844993
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2004
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
-
批准号:7254862
-
项目类别:
-
资助金额:$32.11万
-
财政年份:2004
-
负责人:Gerald J Gleich
-
依托单位:
THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB
-
批准号:6905569
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2004
-
负责人:Gerald J Gleich
-
依托单位:
LIDOCAINE AND SULFONYLUREAS AS GLUCOCORTICOMIMETIC AGENTS
-
批准号:6340658
-
项目类别:
-
资助金额:$14.99万
-
财政年份:2000
-
负责人:Gerald J Gleich
-
依托单位:
海外基金